Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Sales | 6,968 | 9,018 | 6,587 | 8,916 | 10,240 |
| Cost of Goods | 2,008 | 2,317 | 1,201 | 1,716 | 1,665 |
| Gross Profit | 4,960 | 6,701 | 5,386 | 7,200 | 8,576 |
| Operating Expenses | 15,307 | 16,279 | 10,287 | 14,373 | 13,590 |
| Operating Income | -10,339 | -9,261 | -4,700 | -6,457 | -4,350 |
| Other Income | -1,244 | 1,193 | 803 | 1,562 | 909 |
| Pre-tax Income | -11,583 | -8,068 | -3,897 | -4,895 | -3,441 |
| Net Income Continuous | -10,545 | -7,758 | -5,523 | -4,649 | -3,441 |
| Net Income | $-11,584 | $-7,758 | $-3,633 | $-4,649 | $-3,441 |
| EPS Basic Total Ops | -122.39 | -100.79 | -48.97 | -72.00 | -64.11 |
| EPS Basic Continuous Ops | -111.35 | -82.01 | -74.03 | -62.83 | -58.62 |
| EPS Diluted Total Ops | -122.39 | -100.79 | -48.69 | -62.83 | -58.63 |
| EPS Diluted Continuous Ops | -111.35 | -82.01 | -74.03 | -62.83 | -58.62 |
| EBITDA(a) | $-10,339 | $-8,415 | $-4,056 | $-6,457 | $-4,350 |